Email Oxford Health BRC

Oxford Precision Psychiatry Lab (OxPPL)

You are here: Home / Welcome to the Oxford Precision Psychiatry Lab / Publications

Publications

2023

  • Cipriani A, Seedat S, Milligan L, Salanti G, Macleod M, Hastings J, Thomas J, Michie S, Furukawa TA, Gilbert D, McCutcheon R, Ostinelli E.G, Siafis S, Boyce N, Wright S, Elugbadebo O, Simple O, Potts J, Elliott J.H, Elgarf R, et al. New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosis. BMJ Mental Health. 2023.06.08.

2022

  • Muit J.J, van Eijndhoven P. FP, Cipriani A, Dalhuisen I, van Bronswijk S, Furukawa TA, Rhue H.G. Efficacy and acceptability of next step treatment strategies in adults with treatment-resistant major depressive disorder: Protocol for systematic review and network meta-analysis. BMJOpen 2021-056777
  • Cipriani A, Chevance A, Tomlinson A, Ravaud P, Touboul S, Henshall C, Tran V.T. Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals. EBMental 2021-300418
  • Lin Y.H, Sahker E, Shinohara K, Horinouchi N, Ito M, Lelliott M, Cipriani A, Tomlinson A, Baethge C, Furukawa TA. Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000-2020: A systematic review and meta-analysis. EClinicalMedicine 2022.101505
  • Zangani C, Ostinelli E.G, Smith K.A, Hong, J.S.W, Macdonald O, Reen G, Reid K, Vincent C, Syed Sheriff R, Harrison P.J, Hawton K, Pitman A, Bale R, Fazel S, Geddes J.R, Cipriani A. Impact of the COVID-19 pandemic on the global delivery of mental health services and telemental health: systematic review. JMIR Ment Health. 2022.
  • Yoshida K, Seo M, Luo Y, Sahker E, Cipriani A, Leucht S, Iwatsubo T, Efthimiou O, Furukawa TA. Personalised prediction of Alzheimer’s Disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials. J Alzheimers Dis. 2022;89(4)
  • Henshall C, Jones H, Smith T, Cipriani A. Promoting inclusivity by ensuring that all patients with mental health issues are offered research opportunities in the NHS. EBMH. 2022.02.25(1):el
  • Hamza T, Furukawa TA, Orsini N, Cipriani A, Salanti G. Dose-effect meta-analysis for psychopharmacological interventions using randomised data. EBMH. 2022.02.25(1):1-6.
  • Turner EH, Cipriani A, Furukawa TA, Salanti G, de Vries YA. Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials. PLoS Med. 2022.01.19(1):e1003886
  • Taipale H, Schneider-Thoma J, Pinzón-Espinosa J, Radua J, Efthimiou O, Vinkers CH, Mittendorfer-Rutz E, Tomlinson A, Cipriani A, et al. Representation of outcomes of individuals with schizophrenia seen in everyday practice who are ineligible for randomized clinical trials. JAMA Psychiatry. 2022.03.1;79(3):210-218
  • Rotstein A, Levine S.Z, Samara M, Yoshida K, Goldberg Y, Cipriani A, Iwatsubo T, Leucht S, Furukawa TA. Cognitive impairment networks in Alzheimer’s Disease: Analysis of three double-blind randomized, placebo controlled, clinical trials of donepezil. Eur Neuropsychopharmacol. 2022.04;57:50-58
  • Liu Q, Vaci N, Koychev I, Kormilitzin A, Li Z, Cipriani A, Nevdado-Holgado A. Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model. BMC Med. 2022.02.1;20(1):45
  • Levine S.Z, Goldberg Y, Yoshida K, Samara M, Cipriani A, Iwatsubo T, Leucht S, Furukawa TA. Early-and subsequent- response of cognitive functioning in Alzheimer’s Disease: Individual – participant data from five pivotal randomized clinical trials of donepezil. J Psychiatry Res. 2022.04;148:159-164
  • Hamza T, Furukawa TA, Orsini N, Cipriani A, Iglesias C.P, Salanti G. A dose-effect network meta-analysis model with application in antidepressants using restricted cubic splines. Stat Methods Med Res. 2022.02.24:9622802211070256
  • Schneider-Thoma J, Chalkou K, Dörries C, Bighelli I, Ceraso A, Huhn M, Siafis S, Davis J.M, Cipriani A, Furukawa TA, Salanti G, Leucht S. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis. Lancet. 2022.02.26;399(10327):824-836
  • Cortese S, Del Giovane C, Chamberlain S, Philipsen A, Young S, Bilbow A, Cipriani A. Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systematic review and network meta-analysis. BMJ Open. 2022.03.11;12(3):e058102
  • Smith K.A, Torus J, Cipriani A. Teaching telepsychiatry skills: building on the lessons of COVID-19 pandemic to enhance mental health care in the future. JMIR Ment Health. 2022.03.29.
  • Ostinelli E.G, Smith K.A, Zangani C, Ostacher M.J, Lingford-Hughes A.R, Hong J.S.W, Macdonald O, Cipriani A. COVID-19 and substance use disorders: a review for international guidelines for frontline healthcare workers of addiction services. BMC Psychiatry. 2022.03.31;22(1):228
  • O’Dell B, Stevens K, Tomlinson A, Singh I, Cipriani A.  Building trust in artificial intelligence and new technologies in mental health. EBMH. 2022.05.23.10.1136
  • Srikesavan C, Davey Z, Cipriani A, Henshall C. Resilience Enhancement Online Training for Nurses (REsOluTioN): Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols. 2022.07.21.10.2196/37015 
  • Furukawa Y, Hamza T, Cipriani A, Furukawa T, Salanti G, Ostinelli E.G. Optimal dose for aripiprazole for augmentation therapy of antidepressant-refractory depression: preliminary findings based on a systematic review and dose-effect meta-analysis. The British Journal of Psychiatry. 2021.11.15.10.1162/bjp.2021.165 
  • Sariaslan Am, Fanshawe T, Pitkänen J, Cipriani A, Martikainen P, Fazel S. Predicting suicide risk in 137 112 people with severe mental illness in Finland: external validation of the Oxford Mental Illness and Suicide tool (OxMIS). Research Square. 2022.09.02: 10.21203/rs.3.rs-1959949/v1 
  • Henshall C, Ostinelli E.G, Harvey J, Davey Z, Aghanenu B, Cipriani A, Attenburrow MJ. Examining the Effectiveness of Web-Based Interventions to Enhance Resilience in Healthcare Professionals: Systematic Review. JMIR Medical Education. 2022.09.06: 10.2196/34230 
  • Lannes Al, Farhat LC, Del Giovane C, Cipriani A, Revet A, Cortese S. Comparative cardiovascular side effects of medications for attention-deficit / hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis. BMJ Open. 2022.09.27: 10.1136/bmjopen-2022-062748 
  • Hamza T, Chalkou K, Pellegrini F, Kuhle J, Benkert P, Lorscheider J, Zecca C, Iglesias Urrutia CP, Manca A, Furukawa T, Cipriani A, Salanti G. Synthesizing cross-design evidence and cross-format data using network meta-regression. ArXiv. 2022.04.20. 2-s2.0-85127243118 
  • Lin YH, Sahker E, Shinohara K, Horinouchi N, Ito M, Lelliot M, Cipriani A, Tomlinson A, Bawthge C, Furukawa TA. Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000-2020: a systematic review and meta-analysis. EClinical Medicine. 2022.07.
  • Salanti G, Peter N, Tonia T, Holloway A, White IR, Darwish L. Low N, Cipriani A, Cuijpers P, Furukawa TA, et al. The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population. ACP Journals 2022.09.

2021

  • Walsh A, Cao R, Wong D, Kantschuster R, Matini L, Wilson J, Kormilitzin A, South M, Travis S, Bauermeister S. Using item response theory (IRT) to improve the efficiency of the Simple Clinical Colitis Activity Index (SCCAI) for patients with ulcerative colitis. BMC Gastroenterol 2021;21(1).
  • D’Alò GL, De Crescenzo F, Amato L, Cruciani F, Davoli M, Fulceri F, et al. Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis. Health Qual Life Outcomes 2021;19(1).
  • Catalani V, Corkery JM, Guirguis A, Napoletano F, Arillotta D, Zangani C, et al. Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise. Eur Neuropsychopharmacol 2021;49:69-92.
  • Luo Y, Ostinelli EG, Sahker E, Chaimani A, Kataoka Y, Ogawa Y, et al. Antidepressant prescriptions have not fully reflected evolving evidence from cumulative network meta-analyses and guideline recommendations. J Clin Epidemiol 2021;133:14-23.
  • Taquet M, Luciano S, Geddes JR, Harrison PJ. Differential follow-up patterns in COVID-19 and comparison cohorts – Authors’ reply. Lancet Psychiatry 2021;8(5):360-361.
  • Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021;8(5):416-427.
  • Salanti G, Cipriani A, Furukawa TA, Peter N, Tonia T, Papakonstantinou T, et al. An efficient way to assess the effect of COVID-19 on mental health in the general population. Lancet Psychiatry 2021;8(5):e14-e15.
  • Schifano F, Chiappini S, Miuli A, Corkery JM, Scherbaum N, Napoletano F, Arillotta D, Zangani C, et al. New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review. Exp Neurol 2021;339.
  • Ostinelli EG, Zangani C, Giordano B, Maestri D, Gambini O, D’Agostino A, et al. Depressive symptoms and depression in individuals with internet gaming disorder: A systematic review and meta-analysis. J Affective Disord 2021;284:136-142.
  • Miklowitz DJ, Furukawa TA, Cipriani A. Interpreting the Findings of a Meta-analysis of Psychosocial Interventions in Bipolar Disorder. JAMA Psychiatry 2021;78(4):448-449.
  • Michopoulos I, Furukawa TA, Noma H, Kishimoto S, Onishi A, Ostinelli EG, et al. Different control conditions can produce different effect estimates in psychotherapy trials for depression. J Clin Epidemiol 2021;132:59-70.
  • Henshall C, Potts J, Walker S, Hancock M, Underwood M, Broughton N, et al. Informing National Health Service patients about participation in clinical research: A comparison of opt-in and opt-out approaches across the United Kingdom. Aust New Zealand J Psychiatry 2021;55(4):400-408.
  • Solmi M, Wade TD, Byrne S, Del Giovane C, Fairburn CG, Ostinelli EG, et al. Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis. Lancet Psychiatry 2021;8(3):215-224.
  • Bosley H, Appleton JV, Henshall C, Jackson D. The influence of perceived accessibility and expertise of healthcare professionals, and service austerity, on mothers’ decision-making. Health Soc Care Community 2021;29(2):526-534.
  • Taquet M, Luciano S, Geddes JR, Harrison PJ. Disentangling the complex bidirectional associations between COVID-19 and psychiatric disorder – Authors’ reply. Lancet Psychiatry 2021;8(3):179.
  • Lovato I, Pini A, Stamm A, Taquet M, Vantini S. Multiscale null hypothesis testing for network-valued data: Analysis of brain networks of patients with autism. J R Stat Soc Ser C Appl Stat 2021;70(2):372-397.
  • Cruciani F, Amato L, De Crescenzo F, Mitrova Z, Saulle R, Vecchi S, et al. The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19. Recenti Prog Med 2021;112(3):195-206.
  • Leucht S, Cipriani A, Furukawa TA, Peter N, Tonia T, Papakonstantinou T, et al. A living meta-ecological study of the consequences of the COVID-19 pandemic on mental health. Eur Arch Psychiatry Clin Neurosci 2021;271(2):219-221.
  • Quested DJ, Gibson JC, Sharpley AL, Cordey JH, Economou A, De Crescenzo F, et al. Melatonin In Acute Mania Investigation (MIAMI-UK). A randomized controlled trial of add-on melatonin in bipolar disorder. Bipolar Disord 2021;23(2):176-185.
  • Levine SZ, Goldberg Y, Yoshida K, Samara M, Cipriani A, Iwatsubo T, et al. Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil. Eur Psychiatry 2021;64(1):e16.
  • Ralovska S, Koychev I, De Crescenzo F, Marinov P, Cipriani A. Brexpiprazole versus placebo or other antidepressive agents for treating depression. Cochrane Database Syst Rev 2021;2021(2).
  • Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2021;8(2):130-140.
  • Zhou X, Teng T, Del Giovane C, Furukawa TA, Weisz JR, Cipriani A, et al. Treatment of depression in children and adolescents – Authors’ reply. Lancet Psychiatry 2021;8(2):97-98.
  • Henshall C, Davey Z, Walthall H, Ball H, Shahidi M, Park J, et al. Recommendations for improving follow-up care for patients with mesothelioma: A qualitative study comprising documentary analysis, interviews and consultation meetings. BMJ Open 2021;11(1).
  • Smith K, Lambe S, Freeman D, Cipriani A. COVID-19 vaccines, hesitancy and mental health. Evid -Based Ment Health 2021.
  • Seo M, Furukawa TA, Veroniki AA, Pillinger T, Tomlinson A, Salanti G, Cipriani A, Efthimiou O. The Kilim plot: A tool for visualizing network meta-analysis results for multiple outcomes. Res Synth Methods 2021;12(1):86-95.
  • Burden S, Henshall C, Oshikanlu R. Harnessing the nursing contribution to COVID-19 mass vaccination programmes: Addressing hesitancy and promoting confidence. J Adv Nurs 2021.
  • Ferguson C, Henshall C, Albert NM. Global perspectives on under-funding for Clinical Research Training Fellowships in Nursing. J Clin Nurs 2021.
  • Maslej MM, Furukawa TA, Cipriani A, Andrews PW, Sanches M, Tomlinson A, et al. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials. JAMA Psychiatry 2021.
  • Taquet M, Quoidbach J, Fried EI, Goodwin GM. Mood Homeostasis before and during the Coronavirus Disease 2019 (COVID-19) Lockdown among Students in the Netherlands. JAMA Psychiatry 2021;78(1):110-112.
  • Henshall C, Kozlowska O, Walthall H, Heinen A, Smith R, Carding P. Interventions and strategies aimed at clinical academic pathway development for nurses in the United Kingdom: A systematised review of the literature. J Clin Nurs 2021.
  • Xu N, Shinohara K, Saunders KEA, Geddes JR, Cipriani A. Effect of lithium on circadian rhythm in bipolar disorder: A systematic review and meta-analysis. Bipolar Disord 2021.
  • Hamza T, Cipriani A, Furukawa TA, Egger M, Orsini N, Salanti G. A Bayesian dose–response meta-analysis model: A simulations study and application. Stat Methods Med Res 2021.
  • Luo Y, Chaimani A, Furukawa TA, Kataoka Y, Ogawa Y, Cipriani A, et al. Visualizing the evolution of evidence: Cumulative network meta-analyses of new generation antidepressants in the last 40 years. Res Synth Methods 2021;12(1):74-85.
  • Zaccari V, Santonastaso O, Mandolesi L, De Crescenzo F, Foti F, Crescentini C, et al. Clinical application of mindfulness-oriented meditation in children with ADHD: a preliminary study on sleep and behavioral problems. Psychol Health 2021.
  • McCutcheon R, Pillinger T, Welby G, Vano L, Cummings C, Guo X, Heron TA, Efthimiou O, Cipriani A, Howes O. Magnitude and variability of structural brain abnormalities in neuropsychiatric disease: Protocol for a network meta-analysis of MRI studies. Evid -Based Ment Health 2021.
  • Solmi M, Dragioti E, Arango C, Radua J, Ostinelli EG, Kilic O, et al. Risk and protective factors for mental disorders with onset in childhood/adolescence: An umbrella review of published meta-analyses of observational longitudinal studies. Neurosci Biobehav Rev 2021;120:565-573.

2020

  • Kataoka Y, Luo Y, Chaimani A, Onishi A, Kimachi M, Tsujimoto Y, Murad MH, Li T, Cipriani A, Furukawa TA. Cumulative network meta-analyses, practice guidelines, and actual prescriptions for postmenopausal osteoporosis: a meta-epidemiological study. Arch Osteoporosis 2020;15(1).
  • D’Agostino A, Ferrara P, Terzoni S, Ostinelli EG, Carrara C, Prunas C, Gambini O, Destrebecq A. Efficacy of Triple Chronotherapy in unipolar and bipolar depression: A systematic review of the available evidence. J Affective Disord 2020;276:297-304.
  • Morrill JH, Kormilitzin A, Nevado-Holgado AJ, Swaminathan S, Howison SD, Lyons TJ. Utilization of the Signature Method to Identify the Early Onset of Sepsis From Multivariate Physiological Time Series in Critical Care Monitoring. Crit Care Med 2020;48(10):e976-e981.
  • Boaden K, Tomlinson A, Cortese S, Cipriani A. Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment. Front Psychiatry 2020;11.
  • Taquet M, Quoidbach J, Gross JJ, Saunders KEA, Goodwin GM. Mood homeostasis, low mood, and history of depression in 2 large population samples. JAMA Psychiatry 2020;77(9):944-951.
  • Gillett G, Tomlinson A, Efthimiou O, Cipriani A. Predicting treatment effects in unipolar depression: A meta-review. Pharmacol Ther 2020;212.
  • Chevance A, Ravaud P, Tomlinson A, Le Berre C, Teufer B, Touboul S, Fried EI, Gartlehner G, Cipriani A, Tran VT. Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international online survey. Lancet Psychiatry 2020;7(8):692-702.
  • Goodday SM, Kormilitzin A, Vaci N, Liu Q, Cipriani A, Smith T, Nevado-Holgado A. Maximizing the use of social and behavioural information from secondary care mental health electronic health records. J Biomed Informatics 2020;107.
  • Jack RH, Hollis C, Coupland C, Morriss R, Knaggs RD, Butler D, Cipriani A. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998–2017: A population-based cohort study. PLoS Med 2020;17(7).
  • Di Nicola M, De Crescenzo F, D’Alò GL, Remondi C, Panaccione I, Moccia L, Molinaro M, Dattoli L, Lauriola A, Martinelli S, Giuseppin G, Maisto F, Crosta ML, Di Pietro S, Amato L, Janiri L. Pharmacological and Psychosocial Treatment of Adults With Gambling Disorder: A Meta-Review. J Addict Med 2020;14(4):e15-e23.
  • Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 2020;7(7):581-601.
  • Solmi M, Veronese N, Galvano D, Favaro A, Ostinelli EG, Noventa V, Favaretto E, Tudor F, Finessi M, Shin JI, Smith L, Koyanagi A, Cester A, Bolzetta F, Cotroneo A, Maggi S, Demurtas J, De Leo D, Trabucchi M. Factors Associated With Loneliness: An Umbrella Review Of Observational Studies. J Affective Disord 2020;271:131-138.
  • Thompson T, Dias S, Poulter D, Weldon S, Marsh L, Rossato C, Shin JI, Firth J, Veronese N, Dragioti E, Stubbs B, Solmi M, Maher CG, Cipriani A, Ioannidis JPA. Efficacy and acceptability of pharmacological and non-pharmacological interventions for non-specific chronic low back pain: A protocol for a systematic review and network meta-analysis. Syst Rev 2020;9(1).
  • Gillett G. A day in the life of a psychiatrist in 2050: Where will the algorithm take us? BJPsych Bull 2020;44(3):121-123.
  • Maslej MM, Furukawa TA, Cipriani A, Andrews PW, Mulsant BH. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials. JAMA Psychiatry 2020;77(6):607-617.
  • Solmi M, Fornaro M, Ostinelli EG, Zangani C, Croatto G, Monaco F, Krinitski D, Fusar-Poli P, Correll CU. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry 2020;19(2):214-232.
  • Armando M, Ciampoli M, Padula MC, Amminger P, De Crescenzo F, Maeder J, Schneider M, Schaer M, Manago’ F, Eliez S, Papaleo F. Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome. Neuropharmacology 2020;168.
  • Every-Palmer S, Romans SE, Stubbs R, Tomlinson A, Gandhi S, Huthwaite M. Experiences of Weight-Loss Surgery in People With Serious Mental Illness: A Qualitative Study. Front Psychiatry 2020;11.
  • Smith K, Ostinelli E, Cipriani A. Covid-19 and mental health: A transformational opportunity to apply an evidence-based approach to clinical practice and research. Evid -Based Ment Health 2020;23(2):45-46.
  • Tomlinson A, Furukawa TA, Efthimiou O, Salanti G, De Crescenzo F, Singh I, Cipriani A. Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): Rationale and protocol. Evid -Based Ment Health 2020;23(2):52-56.
  • Furukawa TA, Salanti G, Cowen PJ, Leucht S, Cipriani A. No benefit from flexible titration above minimum licensed dose in prescribing antidepressants for major depression: systematic review. Acta Psychiatr Scand 2020;141(5):401-409.
  • Walker S, Potts J, Martos L, Barrera A, Hancock M, Bell S, Geddes J, Cipriani A, Henshall C. Consent to discuss participation in research: A pilot study. Evid -Based Ment Health 2020;23(2):77-82.
  • Jack RH, Joseph RM, Coupland C, Butler D, Hollis C, Morriss R, Knaggs RD, Cipriani A, Cortese S, Hippisley-Cox J. Secondary care specialist visits made by children and young people prescribed antidepressants in primary care: A descriptive study using the QResearch database. BMC Med 2020;18(1).
  • D’Alò GL, De Crescenzo F, Minozzi S, Morgano GP, Mitrova Z, Scattoni ML, Amato L, Davoli M, Schunemann HJ. Equity, acceptability and feasibility of using polyunsaturated fatty acids in children and adolescents with autism spectrum disorder: A rapid systematic review. Health Qual Life Outcomes 2020;18(1).
  • Senior M, Burghart M, Yu R, Kormilitzin A, Liu Q, Vaci N, Nevado-Holgado A, Pandit S, Zlodre J, Fazel S. Identifying Predictors of Suicide in Severe Mental Illness: A Feasibility Study of a Clinical Prediction Rule (Oxford Mental Illness and Suicide Tool or OxMIS). Front Psychiatry 2020;11.
  • Scherrer B, Prohl AK, Taquet M, Kapur K, Peters JM, Tomas-Fernandez X, Davis PE, Bebin M, Krueger DA, Northrup H, Wu J, Sahin M, Warfield K. The Connectivity Fingerprint of the Fusiform Gyrus Captures the Risk of Developing Autism in Infants with Tuberous Sclerosis Complex. Cereb Cortex 2020;30(4):2199-2214.
  • Sheriff RS, Van Hooff M, Malhi G, Grace B, McFarlane A. Childhood trauma and the impact of deployment on the development of mental disorder in military males. Psychol Med 2020;50(5):818-826.
  • Morgano GP, Fulceri F, Nardocci F, Barbui C, Ostuzzi G, Papola D, Fatta LM, Fauci AJ, Coclite D, Napoletano A, De Crescenzo F, D’Alo’ GL, Amato L, Cinquini M, Iannone P, Schunemann HJ, Scattoni ML, Arduino M, Bellosio C, Biasci S. Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health. Health Qual Life Outcomes 2020;18(1).
  • Cipriani A, Ioannidis JPA, Rothwell PM, Glasziou P, Li T, Hernandez AF, Tomlinson A, Simes J, Naci H. Generating comparative evidence on new drugs and devices after approval. Lancet 2020;395(10228):998-1010.
  • Singh I, Naci H, Miller J, Caplan A, Cipriani A. Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships. Lancet 2020;395(10228):926-928.
  • Naci H, Salcher-Konrad M, Kesselheim AS, Wieseler B, Rochaix L, Redberg RF, Salanti G, Jackson E, Garner S, Stroup TS, Cipriani A. Generating comparative evidence on new drugs and devices before approval. Lancet 2020;395(10228):986-997.
  • Furukawa TA, Ogawa Y, Takeshima N, Hayasaka Y, Chen P, Cipriani A, Barbui C. Bupropion versus other antidepressive agents for depression. Cochrane Database Syst Rev 2020;2020(3).
  • Luo Y, Kataoka Y, Ostinelli EG, Cipriani A, Furukawa TA. Corrigendum: National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis (Front. Psychiatry, (2020), 11, 35, 10.3389/fpsyt.2020.00035). Front Psychiatry 2020;11.
  • De Crescenzo F, D’Alò GL, Morgano GP, Minozzi S, Mitrova Z, Saulle R, Cruciani F, Fulceri F, Davoli M, Scattoni ML, Nardocci F, Schunemann HJ, Amato L, Nardocci F. Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: A systematic review. Health Qual Life Outcomes 2020;18(1).
  • Luo Y, Kataoka Y, Ostinelli EG, Cipriani A, Furukawa TA. National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis. Front Psychiatry 2020;11.
  • Vaci N, Liu Q, Kormilitzin A, De Crescenzo F, Kurtulmus A, Harvey J, O’Dell B, Innocent S, Tomlinson A, Cipriani A, Nevado-Holgado A. Natural language processing for structuring clinical text data on depression using UK-CRIS. Evid Based Ment Health 2020;23(1):21-26.
  • Cuijpers P, Noma H, Karyotaki E, Vinkers CH, Cipriani A, Furukawa TA. A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry 2020;19(1):92-107.
  • Smith K, Bhui K, Cipriani A. COVID-19, mental health and ethnic minorities. Evid -Based Ment Health 2020.
  • De Crescenzo F, Garriga C, Tomlinson A, Coupland C, Efthimiou O, Fazel S, Hippisley-Cox J, Cipriani A. Real-world effect of antidepressants for depressive disorder in primary care: Protocol of a population-based cohort study. Evid -Based Ment Health 2020.
  • Seo M, Furukawa TA, Veroniki AA, Pillinger T, Tomlinson A, Salanti G, Cipriani A, Efthimiou O. The Kilim plot: A tool for visualizing network meta-analysis results for multiple outcomes. Res Synth Methods 2020.
  • Gligic L, Kormilitzin A, Goldberg P, Nevado-Holgado A. Named entity recognition in electronic health records using transfer learning bootstrapped Neural Networks. Neural Netw 2020;121:132-139.
  • Taquet M, Quoidbach J, Fried EI, Goodwin GM. Mood Homeostasis before and during the Coronavirus Disease 2019 (COVID-19) Lockdown among Students in the Netherlands. JAMA Psychiatry 2020.
  • Syed Sheriff R, Van Hooff M, Malhi G, Grace B, McFarlane A. Childhood Trauma and Childhood Mental Disorder in Military and Employed Civilian Men. J Nerv Ment Dis 2020;208(1):13-20.
  • Sharpley AL, Williams C, Holder AA, Godlewska BR, Singh N, Shanyinde M, MacDonald O, Cowen PJ. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania. Psychopharmacology 2020.
  • Taquet M, Smith SM, Prohl AK, Peters JM, Warfield SK, Scherrer B, Harrison PJ. A structural brain network of genetic vulnerability to psychiatric illness. Mol Psychiatry 2020.
  • Williams T, McCaul M, Schwarzer G, Cipriani A, Stein DJ, Ipser J. Pharmacological treatments for social anxiety disorder in adults: A systematic review and network meta-analysis. Acta Neuropsychiatr 2020.
  • Ferrara P, D’Agostino A, Terzoni S, Ostinelli EG, Cavallotti S, Basi C, Bertino V, Gambini O, Destrebecq A. Triple Chronotherapy approach for reducing depressive symptoms and suicidal intent in hospitalized patients: Study protocol of a Randomized Controlled Trial. Prof Inferm 2020;73(1):21-25.
  • Luo Y, Chaimani A, Furukawa TA, Kataoka Y, Ogawa Y, Cipriani A, Salanti G. Visualizing the evolution of evidence: Cumulative network meta-analyses of new generation antidepressants in the last 40 years. Res Synth Methods 2020.
  • Bartoli F, Ostuzzi G, Crocamo C, Corbo M, D’Agostino A, Martinotti G, Ostinelli EG, Tabacchi T, Barbui C, Carra’ G. Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophreniaspectrum disorders: Findings from the STAR Network Depot Study. Int Clin Psychopharmacol 2020;35(4):214-220.
  • Ostinelli EG, D’Agostino A, Pesce L, Zangani C, Miragoli P, Durbano F, Biffi G, Mencacci C, Scarone S, Gambini O. Mental health services and the city: a neighbourhood-level epidemiological study. J Public Health 2020.
  • Minichino A, Brondino N, Solmi M, Del Giovane C, Fusar-Poli P, Burnet P, Cipriani A, Lennox BR. The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies. Schizophr Res 2020.
  • Witt K, Potts J, Hubers A, Grunebaum MF, Murrough JW, Loo C, Cipriani A, Hawton K. Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials. Aust New Zealand J Psychiatry 2020;54(1):29-45.
  • Quested DJ, Gibson JC, Sharpley AL, Cordey JH, Economou A, De Crescenzo F, Voysey M, Lawson J, Rendell JM, Al-Taiar H, Lennox A, Ahmad F, Geddes JR. Melatonin In Acute Mania Investigation (MIAMI-UK). A randomized controlled trial of add-on melatonin in bipolar disorder. Bipolar Disord 2020.
  • Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, Beck K, Natesan S, Efthimiou O, Cipriani A, Howes OD. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry 2020;7(1):64-77.
  • Sanghani HR, Jagannath A, Humberstone T, Ebrahimjee F, Thomas JM, Churchill GC, Cipriani A, Attenburrow MJ, Perestenko OV, Cowley SA, Cader MZ, Peirson SN, Harrison PJ, Foster RG, Goodwin GM, Vasudevan SR. Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorder. Mol Psychiatry 2020.
  • Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, Meersmans K, Engelborghs, De Roeck EE. Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer’s disease multimodal biomarker discovery cohort. J Alzheimer’s Dis 2020;74(1):213-225.
  • MacDonald O, Smith K, Marven M, Broughton N, Geddes J, Cipriani A. How pharmacist prescribers can help meet the mental health consequences of COVID-19. Evid -Based Ment Health 2020;23(4):131.
  • Aceto P, Lai C, De Crescenzo F, Crea MA, Di Franco V, Pellicano GR, et al. Cognitive decline after carotid endarterectomy: Systematic review and meta-analysis. Eur J Anaesthesiol 2020;37(11):1066-1074.
  • Gillett G, Jordan I. Severe psychiatric disturbance and attempted suicide in a patient with COVID-19 and no psychiatric history. BMJ Case Rep 2020;13(10).
  • Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2020.
  • Solmi M, Dragioti E, Arango C, Radua J, Ostinelli E, Kilic O, et al. Risk and protective factors for mental disorders with onset in childhood/adolescence: An umbrella review of published meta-analyses of observational longitudinal studies. Neurosci Biobehav Rev 2020.
  • Barbui C, Nosè M, Purgato M, […] Ostinelli E, et al. Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophreniaspectrum disorders: Findings from the STAR Network Depot Study. Int Clin Psychopharmacol 2020;35(4):214-220.

2019

  • Quoidbach J, Sugitani Y, Gross JJ, Taquet M, Akutsu S. From affect to action: How pleasure shapes everyday decisions in Japan and the U.S. Motiv Emot 2019;43(6):948-955.
  • Taquet M, Jankovski A, Rensonnet G, Jacobs D, des Rieux A, Macq B, Warfield SK, Scherrer B. Extra-axonal restricted diffusion as an in-vivo marker of reactive microglia. Sci Rep 2019;9(1).
  • Ostinelli EG, Zangani C, Solmi M. Clozapine for persistent aggressive behaviour or agitation in people with schizophrenia. Cochrane Database Syst Rev 2019;2019(11).
  • Tomlinson A, Boaden K, Cipriani A. Withdrawal, dependence and adverse events of antidepressants: Lessons from patients and data. Evid -Based Ment Health 2019;22(4):137-138.
  • Duffy A, Saunders KEA, Malhi GS, Patten S, Cipriani A, McNevin SH, MacDonald E, Geddes J. Mental health care for university students: a way forward? Lancet Psychiatry 2019;6(11):885-887.
  • Tunbridge EM, Narajos M, Harrison CH, Beresford C, Cipriani A, Harrison PJ. Which Dopamine Polymorphisms Are Functional? Systematic Review and Meta-analysis of COMT, DAT, DBH, DDC, DRD1–5, MAOA, MAOB, TH, VMAT1, and VMAT2. Biol Psychiatry 2019;86(8):608-620.
  • Jochim J, Rifkin-Zybutz RP, Geddes J, Cipriani A. Valproate for acute mania. Cochrane Database Syst Rev 2019;2019(10).
  • Ostinelli EG, D’Agostino A, Shokraneh F, Salanti G, Furukawa TA. Acute interventions for aggression and agitation in psychosis: Study protocol for a systematic review and network meta-analysis. BMJ Open 2019;9(10).
  • Syed Sheriff R, Van Hooff M, Malhi G, Grace B, McFarlane A. Associations Among Childhood Trauma, Childhood Mental Disorders, and Past-Year Posttraumatic Stress Disorder in Military and Civilian Men. J Trauma Stress 2019;32(5):712-723.
  • Sheriff RS, Van Hooff M, Malhi G, Grace B, McFarlane A. Associations of childhood trauma and childhood mental disorder with past-year mental disorder in military and civilian employed men. Psychiatry Res 2019;280.
  • Sheriff RS, Van Hooff M, Malhi G, Grace B, Mcfarlane A. Childhood determinants of suicidality: comparing males in military and civilian employed populations. Psychol Med 2019;49(14):2421-2431.
  • Furukawa TA, Cowen PJ, Salanti G, Leucht S, Egger M, Cipriani A. Optimal dosing of antidepressant drugs – Authors’ reply. Lancet Psychiatry 2019;6(10):806-807.
  • Leucht S, Chaimani A, Mavridis D, Leucht C, Huhn M, Helfer B, Samara M, Cipriani A, Geddes JR, Davis JM. Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis. Neuropsychopharmacology 2019;44(11):1955-1966.
  • Zhou X, Liu L, Lan X, Cohen D, Zhang Y, Ravindran AV, Yan S, Zheng P, Coghill D, Yang L, Hetrick SE, Jiang X, Benoliel JJ, Cipriani A, Xie P. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents. Mol Psychiatry 2019;24(10):1478-1488.
  • Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Backers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 2019;394(10202):939-951.
  • The Signature-Based Model for Early Detection of Sepsis from Electronic Health Records in the Intensive Care Unit. Computing in Cardiology; 2019.
  • Minichino A, Senior M, Brondino N, Zhang SH, Godwlewska BR, Burnet PWJ, Cipriani A, Lennox BR. Measuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic Review and Meta-analysis. JAMA Psychiatry 2019;76(9):914-923.
  • Kernot C, Tomlinson A, Chevance A, Cipriani A. One step closer to personalised prescribing of antidepressants: using real-world data together with patients and clinicians’ preferences. Evid Based Ment Health 2019;22(3):91-92.
  • Tundo A, de Filippis R, De Crescenzo F. Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis. Acta Psychiatr Scand 2019;140(2):116-125.
  • Del Giovane C, Cortese S, Cipriani A. Combining Pharmacological and Nonpharmacological Interventions in Network Meta-analysis in Psychiatry. JAMA Psychiatry 2019;76(8):867-868.
  • Quoidbach J, Taquet M, Desseilles M, de Montjoye Y-, Gross JJ. Happiness and Social Behavior. Psychol Sci 2019;30(8):1111-1122.
  • Jack RH, Hollis C, Coupland C, Morriss R, Knaggs RD, Cipriani A, Cortese S, Hippisley-Cox J. Trends in antidepressant prescriptions in children and young people in England, 1998-2017: Protocol of a cohort study using linked primary care and secondary care datasets. Evid -Based Ment Health 2019;22(3):129-133.
  • Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults with Depression: A Network Meta-analysis. JAMA Psychiatry 2019;76(7):700-707.
  • Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry 2019;6(7):601-609.
  • Peters JM, Struyven RR, Prohl AK, Vasung L, Stajduhar A, Taquet M, Bushman JJ, Lidov H, Singh JM, Scherrer B, Madsen JR, Prabhu SP, Sahin M, Afacan O, Warfield SK. White matter mean diffusivity correlates with myelination in tuberous sclerosis complex. Ann Clin Transl Neurol 2019;6(7):1178-1190.
  • Gillett G, Saunders KEA. Remote Monitoring for Understanding Mechanisms and Prediction in Psychiatry. Cur Behav Neurosci Rep 2019;6(2):51-56.
  • McKnight RF, de La Motte de Broöns de Vauvert,S.J.G.N., Chesney E, Amit BH, Geddes J, Cipriani A. Lithium for acute mania. Cochrane Database Syst Rev 2019;2019(6).
  • Shinohara K, Efthimiou O, Ostinelli EG, Tomlinson A, Geddes JR, Nierenberg AA, Ruhe HG, Furukawa TA, Cipriani A. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: Protocol for a systematic review and networkmeta-analysis. BMJ Open 2019;9(5).
  • Henshall C, Cipriani A, Ruvolo D, Macdonald O, Wolters L, Koychev I. Implementing a digital clinical decision support tool for side effects of antipsychotics: A focus group study. Evid -Based Ment Health 2019;22(2):56-60.
  • Gillett G. Parity of esteem? Stop delaying liaison psychiatry assessment. Lancet Psychiatry 2019;6(5):372.
  • Jones H, Cipriani A. Barriers and incentives to recruitment in mental health clinical trials. Evid -Based Ment Health 2019;22(2):49-50.
  • Tomlinson A, Efthimiou O, Boaden K, New E, Mather S, Salanti G, Imai H, Ogawa Y, Tajika A, Kishimoto S, Kikuchi S, Chevance A, Furukawa TA, Cipriani A. Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: Protocol for a network meta-analysis. Evid -Based Ment Health 2019;22(2):61-66.
  • Noma H, Furukawa TA, Maruo K, Imai H, Shinohara K, Tanaka S, Ikeda K, Yamawaki S, Cipriani A. Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials. J Affective Disord 2019;250:419-424.
  • Witt K, Boland A, Lamblin M, McGorry PD, Veness B, Cipriani A, Hawton K, Harvey S, Christensen H, Robinson J. Effectiveness of universal programmes for the prevention of suicidal ideation, behaviour and mental ill health in medical students: A systematic review and meta-analysis. Evid -Based Ment Health 2019;22(2):84-90.
  • Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Di Florio A, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones J, Kasper S, MacRitchie K, Hamish McAllister-Williams R, Morriss R, Nayrouz S, Pappa S, Soares JC, Smith DJ, Suppes T, Talbot P, Vieta E, Watson S, Yatham LN. Corrigendum: Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: A consensus definition (The British Journal of Psychiatry (2019) 214 (27-35) DOI: 10.1192/bjp.2018.257). Br J Psychiatry 2019;214(5):309.
  • Gillett G. Pink and blue: The role of gender in psychiatric diagnosis. J Med Ethics 2019;45(4):271-274.
  • Wu S, Gao L, Cipriani A, Huang Y, Yang Z, Yang J, Yu S, Zhang Y, Chai S, Zhang Z, Sun F, Zhan S. The effects of incretin-based therapies on β-cell function and insulin resistance in type 2 diabetes: A systematic review and network meta-analysis combining 360 trials. Diabetes Obes Metab 2019;21(4):975-983.
  • Walsh A, Kormilitzin A, Hinds C, Sexton V, Brain O, Keshav S, Uhlig H, Geddes J, Goodwin G, Peters M, Collins G, Travis S. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis. J Crohn’s Colitis 2019;13(4):424-430.
  • Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies SJC, Furukawa TA, Koesters M. Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database Syst Rev 2019;2019(3).
  • Puntis S, Minichino A, De Crescenzo F, Cipriani A, Lennox B. Specialised early intervention teams for first episode psychosis. Cochrane Database Syst Rev 2019;2019(3).
  • Puntis S, Minichino A, De Crescenzo F, Cipriani A, Lennox B. Specialised early intervention teams (extended time) for first episode psychosis. Cochrane Database Syst Rev 2019;2019(3).
  • Gillett G. Advance decisions in dementia: When the past conflicts with the present. J Med Ethics 2019;45(3):204-208.
  • Segev A, Evans A, Hodsoll J, Whiskey E, Sheriff RS, Shergill S, MacCabe JH. Hyoscine for clozapine-induced hypersalivation: A double-blind, randomized, placebo-controlled cross-over trial. Int Clin Psychopharmacol 2019;34(2):101-107.
  • Mavridis D, Salanti G, Furukawa TA, Cipriani A, Chaimani A, White IR. Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis. Stat Med 2019;38(5):720-737.
  • Atkinson LZ, Colbourne L, Smith A, Harmer CH, Nobre AC, Rendell J, Jones H, Hinds C, Mould A, Tunbridge EM, Cipriani A, Geddes JR, Saunders KEA, Harrison PJ. The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study. Trials 2019;20(1).
  • Cipriani A, Tomlinson A. Providing the most appropriate care to our individual patients. Evid -Based Ment Health 2019;22(1):1-2.
  • Cortese S, Tomlinson A, Cipriani A. Meta-Review: Network Meta-Analyses in Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 2019;58(2):167-179.
  • Goodday SM, Cipriani A. Challenges in identifying behavioural markers of bipolar disorder through objective smartphone data. Aust New Zealand J Psychiatry 2019;53(2):168-169.
  • Shinohara K, Tanaka S, Imai H, Noma H, Maruo K, Cipriani A, Yamawaki S, Furukawa TA. Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: A pooled analysis of individual patient data. Evid -Based Ment Health 2019;22(1):10-16.
  • Gillett G. Studying medicine in a war zone. BMJ 2019;364:j4380.
  • Ostinelli EG, Cavallotti S, Fanti V, Demartini B, Gambini O, D’Agostino A. The reMAP project: A retrospective, 15-year register study on inpatient care for youth with mental disorders. Early Intervent Psychiatry 2019.
  • De Crescenzo F, Postorino V, Siracusano M, Riccioni A, Armando M, Curatolo P, Mazzone L. Autistic symptoms in schizophrenia spectrum disorders: A systematic review and meta-analysis. Front Psychiatry 2019;10(FEB).
  • Rensonnet G, Scherrer B, Girard G, Jankovski A, Warfield SK, Macq B, Thiran JP, Taquet M. Towards microstructure fingerprinting: Estimation of tissue properties from a dictionary of Monte Carlo diffusion MRI simulations. Neuroimage 2019;184:964-980.
  • Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J, Ware M, Marmorstein N, Cipriani A, Dendukuri N, Mayo N. Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis. JAMA Psychiatry 2019.
  • Gao L, Yu S, Cipriani A, Wu S, Huang Y, Zhang Z, Yang J, Sun Y, Yang Z, Chai S, Zhang Y, Ji L, Zhan S, Sun F. Neurological manifestation of incretin-based therapies in patients with type 2 diabetes: A systematic review and network meta-analysis. Aging Dis 2019;10(6):1311-1319.
  • Zhou X, Zhang Y, Furukawa TA, Cuijpers P, Pu J, Weisz JR, Yang L, Hetrick SE, Del Giovane C, Cohen D, James AC, Yuan S, Whittington C, Jiang X, Teng T, Cipriani A, Xie P. Different Types and Acceptability of Psychotherapies for Acute Anxiety Disorders in Children and Adolescents: A Network Meta-analysis. JAMA Psychiatry 2019;76(1):41-50.
  • Hidalgo-Mazzei D, Berk M, Cipriani A, Cleare AJ, Florio AD, Dietch D, Geddes JR, Goodwin GM, Grunze H, Hayes JF, Jones I, Kasper S, Macritchie K, McAllister-Williams RH, Morriss R, Nayrouz S, Pappa S, Soares JC, Smith DJ, Suppes T, Talbot P, Vieta E. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: Consensus definition. Br J Psychiatry 2019;214(1):27-35.

2018

  • Luo Y, Chaimani A, Kataoka Y, Ostinelli EG, Ogawa Y, Cipriani A, Salanti G, Furukawa TA. Evidence synthesis, practice guidelines and real-world prescriptions of new generation antidepressants in the treatment of depression: A protocol for cumulative network meta-analyses and meta-epidemiological study. BMJ Open 2018;8(12).
  • Tundo A, De Crescenzo F, Gori D, Cavalieri P. Long-term treatment response to continuous cycling course in bipolar disorders: A meta-analysis. J Affective Disord 2018;241:367-370.
  • Kataoka Y, Luo Y, Chaimani A, Onishi A, Kimachi M, Tsujimoto Y, Murad MH, Li T, Cipriani A, Furukawa TA. Cumulative network-meta-analyses, practice guidelines and actual prescriptions of drug treatments for postmenopausal osteoporosis: A study protocol for cumulative network meta-analyses and meta-epidemiological study. BMJ Open 2018;8(12).
  • Furukawa TA, Karyotaki E, Suganuma A, Pompoli A, Ostinelli EG, Cipriani A, Cuijpers P, Efthimiou O. Dismantling, personalising and optimising internet cognitive-behavioural therapy for depression: A study protocol for individual participant data component network meta-analysis. BMJ Open 2018;8(11).
  • Duffy A, Heffer N, Goodday SM, Weir A, Patten S, Malhi GS, Cipriani A. Efficacy and tolerability of lithium for the treatment of acute mania in children with bipolar disorder: A systematic review: A report from the ISBD-IGSLi joint task force on lithium treatment. Bipolar Disord 2018;20(7):583-593.
  • Cipriani A, Adamo N, Giovane CD, Coghill D, Banaschewski T, Hollis C, Zuddas AJ, Simonoff E, Cortese S. Unbalanced risk-benefit analysis of ADHD drugs – Authors’ reply. Lancet Psychiatry 2018;5(11):871-873.
  • Leucht S, Chaimani A, Leucht C, Huhn M, Mavridis D, Helfer B, Samara M, Cipriani A, Geddes JR, Salanti G, Davis JM. 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response. Schizophr Res 2018;201:315-323.
  • Leucht S, Levine SZ, Samara M, Cipriani A, Davis JM, Furukawa TA. Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why? Eur Arch Psychiatry Clin Neurosci 2018;268(7):621-623.
  • Cipriani A, Salanti G, Furukawa TA, Turner E, Ioannidis JPA, Geddes JR. Network meta-analysis of antidepressants – Authors’ reply. Lancet 2018;392(10152):1012-1013.
  • Smith KA, Cipriani A, Hawton KE. Modelling suicide in bipolar disorders: Limitations and opportunities. Bipolar Disord 2018;20(6):566-567.
  • Cipriani A, Williams T, Nikolakopoulou A, Salanti G, Chaimani A, Ipser J, Cowen PJ, Geddes JR, Stein DJ. Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: A network meta-analysis. Psychol Med 2018;48(12):1975-1984.
  • De Giorgi R, Cassar C, D’Alo’ GL, Ciabattini M, Minozzi S, Economou A, Tambelli R, Lucchese F, Saulle R, Amato L, Janiri L, De Crescenzo F. Psychosocial interventions in stimulant use disorders: A systematic review and qualitative synthesis of randomized controlled trials. Riv Psichiatr 2018;53(5):233-255.
  • Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, Atkinson LZ, Tessari L, Banaschewski T, Coghill D, Hollis C, Simonoff E, Zuddas A, Barbui C, Purgato M, Steinhausen HC, Shokraneh F, Xia J, Cipriani A. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 2018;5(9):727-738.
  • Tomlinson A, Cipriani A. The times they are a-changin’. Evid -Based Ment Health 2018;21(3):81.
  • Tomlinson A, Lythe V, Ravi K, Lennox BR, Hawton K. Mental health: a global focus 2018. Lancet Psychiatry 2018;5(8):617.
  • Calati R, Fang F, Mostofsky E, Shen Q, DI Mattei VE, Garcia-Foncillas J, Baca-Garcia E, Cipriani A, Courtet P. Cancer and suicidal ideation and behaviours: Protocol for a systematic review and meta-analysis. BMJ Open 2018;8(8).
  • Ostuzzi G, Mazzi MA, Terlizzi S, Bertolini F, Aguglia A, Bartoli F, Bortolasco P, Callegari C, Caroleo M, Carra’ G, Corbo M, D’Agostino A, Gastaldon C, Lucii C, Magliocco F, Martinotti G, Nose’ M, Ostinelli EG, Papola D, Piccinelli MP, PIccoli A. Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy. PLoS ONE 2018;13(8).
  • Shokraneh F, Adams CE, Clarke M, Amato L, Bastian H, Beller E, Brassey J, Buchbinder R, Davoli M, Del Mar C, Glasziou P, Gluud C, Heneghan C, Hoffmann T, Ioannidis JP, Jayaram M, Kwong J, Moher D, Ota E, Sheriff RS, Vale L, Goldacre B. Why Cochrane should prioritise sharing data. BMJ 2018;362:k3229.
  • Davies C, Radua J, Cipriani A, Stahl D, Provenzani U, McGuire P, Fusar-Poli P. Efficacy and acceptability of interventions for attenuated positive psychotic symptoms in individuals at clinical high risk of psychosis: A network meta-analysis. Front Psychiatry 2018;9(JUN).
  • De Crescenzo F, Ziganshina LE, Yudina EV, Kaplan YC, Ciabattini M, Wei Y, Hoyle CHV. Noradrenaline reuptake inhibitors (NRIs) for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev 2018;2018(6).
  • Cipriani A, Cowen PJ. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel. Lancet Psychiatry 2018;5(6):453-455.
  • Davies C, Cipriani A, Ioannidis JPA, Radua J, Stahl D, Provenzani U, McGuire P, Fusar-Poli P. Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry 2018;17(2):196-209.
  • Furukawa TA, Efthimiou O, Weitz ES, Cipriani A, Keller MB, Kocsis JH, Klein DN, Michalak J, Salanti G, Cuijpers P, Schramm E. Cognitive-behavioral analysis system of psychotherapy, drug, or their combination for persistent depressive disorder: Personalizing the treatment choice using individual participant data network metaregression. Psychother Psychosom 2018;87(3):140-153.
  • Furukawa TA, Maruo K, Noma H, Tanaka S, Imai H, Shinohara K, Ikeda K, Yamawaki S, Levine SZ, Goldberg Y, Leucht S, Cipriani A. Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta-analysis. Acta Psychiatr Scand 2018;137(6):450-458.
  • Cipriani A, Salanti G, Furukawa TA, Egger M, Leucht S, Ruhe HG, Turner EH, Atkinson LZ, Chaimani A, Higgins JPT, Ogawa Y, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Antidepressants might work for people with major depression: where do we go from here? Lancet Psychiatry 2018;5(6):461-463.
  • Ostinelli EG, Hussein M, Ahmed U, Rehman F-, Miramontes K, Adams CE. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev 2018;2018(4).
  • Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018;391(10128):1357-1366.
  • Bighelli I, Castellazzi M, Cipriani A, Girlanda F, Guaiana G, Koesters M, Turrini G, Furukawa TA, Barbui C. Antidepressants versus placebo for panic disorder in adults. Cochrane Database Syst Rev 2018;2018(4).
  • Rensonnet G, Scherrer B, Warfield SK, Macq B, Taquet M. Assessing the validity of the approximation of diffusion-weighted-MRI signals from crossing fascicles by sums of signals from single fascicles. Magn Reson Med 2018;79(4):2332-2345.
  • Wu S, Cipriani A, Yang Z, Yang J, Cai T, Xu Y, Quan X, Zhang Y, Chai S, Sun F, Zhan S. The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis. Expert Opin Drug Saf 2018;17(3):243-249.
  • Atkinson LZ, Cipriani A. How to carry out a literature search for a systematic review: A practical guide. BJPsych Adv 2018;24(2):74-82.
  • Nikolakopoulou A, Mavridis D, Furukawa TA, Cipriani A, Tricco AC, Straus SE, Siontis GCM, Egger M, Salanti G. Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: Empirical study. BMJ (Online) 2018;360.
  • Furukawa TA, Cipriani A, Leucht S, Atkinson LZ, Ogawa Y, Takeshima N, Hayasaka Y, Chaimani A, Salanti G. Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy. Evid -Based Ment Health 2018;21(1):1-3.
  • Ostinelli EG, Jajawi S, Spyridi S, Sayal K, Jayaram MB. Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev 2018;2018(1).
  • Smith K. Network meta-analysis: A useful tool for comparing different psychological treatments for panic disorder?: Commentary on… cochrane corner. BJPsych Adv 2018;24(1):3-8.
  • De Crescenzo F, Ciabattini M, D’Alò GL, De Giorgi R, Del Giovane C, Cassar C, Janiri L, Clark N, Ostacher MJ, Cipriani A. Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis. PLoS Med 2018;15(12).
  • Awad A, Cipriani A. Mood instability and regulatory oversight: Checkpoints on the pursuit of ‘true’ mood stabilisers. Aust New Zealand J Psychiatry 2018;52(1):87-88.
  • Salanti G, Chaimani A, Furukawa TA, Higgins JPT, Ogawa Y, Cipriani A, Egger M. Impact of placebo arms on outcomes in antidepressant trials: Systematic review and meta-regression analysis. Int J Epidemiol 2018;47(5):1454-1464.
  • Ogawa Y, Furukawa TA, Takeshima N, Hayasaka Y, Atkinson LZ, Tanaka S, Cipriani A, Salanti G. Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials. Int Clin Psychopharmacol 2018;33(2):66-72.
  • Zhou X, Cipriani A, Furukawa TA, Cuijpers P, Zhang Y, Hetrick SE, Pu j, Yuan S, Del Giovane C, Xie P. Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: Protocol of an individual patient data meta-analysis. BMJ Open 2018;8(1).